Shree Ram Proteins Limited: EOGM Approves Sale of Undertaking and Capital Raise via QIP
Shree Ram Proteins Limited's EOGM on March 5, 2026, approved the sale of its undertaking and a Qualified Institutions Placement (QIP). The sale of undertaking received 7,714,361 favourable votes, while the QIP saw 16,433,040 favourable votes.
The approval of the sale of an undertaking and a capital raise through QIP are significant corporate actions that can substantially alter the company's structure, financial standing, and future growth prospects.
The company received strong shareholder approval for both the sale of its undertaking and a capital raise via QIP, indicating positive investor sentiment towards these strategic decisions.
Shree Ram Proteins Limited held an Extra Ordinary General Meeting (EOGM) on March 5, 2026, conducted via Video Conferencing / Other Audio Visual Means (VC/OAVM). The meeting focused on two key resolutions.
The first resolution, an ordinary resolution, concerned the approval for the sale of the company's undertaking as a material related party transaction under Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI (LODR) Regulations, 2015. This resolution saw overwhelming support, with 47 members voting in favour, casting 7,714,361 votes. There were no votes against the resolution. However, 7 members cast invalid votes amounting to 8,733,679.
The second ordinary resolution was to raise capital by way of Qualified Institutions Placement (QIP) to eligible investors through an issuance of equity shares and/or other eligible securities. This resolution also received strong backing, with 53 members voting in favour and casting 16,433,040 votes. Only one member voted against, with 15,000 votes. There were no invalid votes for this resolution.
The Scrutinizer's report, submitted by Payal Dhamecha, details the remote e-voting process managed by National Securities Depository Limited (NSDL). The cut-off date for e-voting eligibility was February 26, 2026. The e-voting results were unblocked on March 5, 2026, at 3:54 pm in the presence of witnesses.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.